State of Medtech

Winning markets rarely begins with building a better product. It begins with changing how customers think. In this solo episode, Omar Khateeb explores why category design is the first discipline of Market Engineering and how market leaders consistently create new buying frameworks before competitors recognize the opportunity. Using examples from Tesla, Red Bull, Intuitive Surgical, and the Play Bi...

Enterprise AI: Why the Interface Matters More Than the Mode! Most conversations about artificial intelligence focus on models. The real transformation is happening somewhere else. In this episode, Omar Khateeb welcomes Harry Glorikian, General Partner at Scientia Ventures, to discuss how invisible interfaces, AI agents, enterprise workflows, and organizational redesign are changing the future of b...

This Month in MedTech What the Biggest MedTech Deals Reveal About the Future of Healthcare. June delivered one of the clearest signals yet about where MedTech strategy is heading. In this episode, Omar Khateeb speaks with Henry Peck, Chief Business Officer at LSI, about the deals, investment patterns, and strategic decisions defining the current MedTech market. The discussion covers Medtronic’s tw...

The Infrastructure Behind Intelligent Medical Devices. Medical innovation is becoming increasingly intelligent. The infrastructure supporting those devices must evolve just as quickly. In this episode, Omar Khateeb speaks with Omari Bouknight, CEO & Board Director of Resonant Link Medical, about the role wireless power will play in the future of implantable healthcare. The conversation covers...

Why Product Market Fit Is Only the Beginning! Most startups spend years chasing traction. Very few spend enough time understanding what happens after they achieve it. In this solo episode, Omar Khateeb explains why product-market fit creates opportunity but does not create protection. Growth attracts customers, but it also attracts competitors, capital, strategic interest, and market attention. Th...

Most surgical innovation focuses on what happens during or after a procedure. Saahil Mehta believes the bigger opportunity may exist before surgery ever starts. In this episode, Omar Khateeb speaks with the Founder of Plexāā about prehabilitation, tissue conditioning, breast reconstruction, patient education, and the role preparation plays in long-term recovery. The discussion examines how heat sh...

In this solo episode, Omar Khateeb explores why many startups struggle immediately after gaining traction. The challenge is rarely the technology. The challenge is the buyer. Early adopters and mainstream customers make decisions for completely different reasons. One group rewards innovation and vision. The other rewards certainty, references, evidence, and proven outcomes. The conversation examin...

Omar Khateeb speaks with Nishant Doctor, Founder, CEO, and CTO of Surf Therapeutics , about the next frontier of neurotechnology: using ultrasound neuromodulation to target inflammation. Nishant breaks down the science behind the cholinergic anti-inflammatory pathway, why the splenic nerve may offer a more direct target than the vagus nerve, and how non-invasive stimulation could create a differen...

The Psychology of Startups vs Corporations. In this solo episode, Omar Khateeb examines the hidden forces that shape career satisfaction, professional growth, and long term success. Using the Barbarians to Bureaucrats framework, the conversation explores how organizations evolve through different stages and why each stage attracts a different type of personality. Visionaries, builders, operators,...

Why Great Markets Create More Value Than Great Products! In this episode, Omar Khateeb speaks with Bruce Cleveland, Chief Executive Officer of Traction Gap Partners and author of Market Engineering , about one of the most overlooked drivers of company success: market creation. Drawing from his experience helping build Oracle, Siebel Systems, and C3 AI, Bruce explains why many companies focus heavi...

In this episode of This Month in MedTech , Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now. The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart , and the latest M&A activity from J&J, Medtronic, ResMed, Roch...

In this episode, Omar Khateeb speaks with Matt Curl, Chief Executive Officer at Apollo.io , about AI native go to market systems, modern revenue growth, and why great products rarely win markets on their own. Matt shares how Apollo.io built one of the leading go to market platforms serving hundreds of thousands of businesses worldwide and explains why modern GTM now depends on real time data, auto...

In this episode, Omar Khateeb explores the Elephant Slide framework and why it is becoming an essential leadership tool in MedTech boardrooms. The discussion breaks down why disconnected operational updates often create fragmented board conversations around clinical milestones, financing, regulatory progress, commercialization, and market confidence. Omar explains how strong CEOs use strategic nar...

In this episode, Omar Khateeb speaks with Deborah K. and Virginia Giddings of Edwards Lifesciences about the future of MedTech innovation, venture capital, and strategic investment. The conversation explores why great technology and clinical superiority alone rarely create adoption in MedTech. Topics include startup failure rates, acquisition pathways, AI-enabled robotics, minimally invasive thera...

In this solo episode, Omar Khateeb explores the psychology of winning companies through the lens of barbarians, bureaucrats, and hardball strategy. The episode connects lessons from Rome, Alexander the Great, Ray Kroc, Steve Jobs, Elon Musk, Intuitive, and MedTech startups to explain why speed, urgency, and conviction often beat comfort and process. Omar also breaks down why barbarian energy is po...

In this episode, Omar Khateeb speaks with Chris Darland, President & CEO of Peerbridge Health , about the future of AI driven cardiac intelligence and preventive heart care. Peerbridge Health is building a platform designed to move cardiology from reactive intervention toward earlier detection through wearable ECG technology, software intelligence, and high fidelity cardiac data. Chris explain...

In this episode, Omar Khateeb explores the hidden infrastructure behind AI, media, and markets: attention. The discussion traces how Google organized attention through PageRank, how social media platforms monetized it through engagement systems, and how AI models now operationalize it through transformer architectures built around attention mechanisms. Omar also dives into the psychology of focus,...

In this episode, Omar Khateeb sits down with Fazila Seker, CEO and Board Director of Insight Medbotics, to explore how meaningful MedTech innovation starts by solving real clinical problems. Fazila shares how her team uncovered a major gap in prostate cancer care by closely observing how physicians use MRI today. That insight led to the development of an MRI-native platform designed to unify diagn...

In this episode of This Month in MedTech 2026 , April brings a sharper look at where the market is heading. The discussion covers Medtronic’s $100M investment in Pulnovo , why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals acro...

In this episode, Omar Khateeb speaks with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, about how autonomous surgery could redefine surgical robotics. Nick shares how Andromeda is approaching the market differently by focusing on software, autonomy, and real-world surgical data rather than building another traditional robotics platform. The discussion covers their first beachhead in urol...

In this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained mar...

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures , about what makes a medtech company investable at the early stage. From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplin...

In this episode, Omar Khateeb, Founder of Marketcraft , takes a focused look at technology adoption and what it really takes to move from early traction to mainstream scale. This solo conversation highlights why many companies gain initial momentum but struggle to sustain growth. Omar explains the shift from vision-driven early adopters to pragmatic mainstream buyers, and why this transition requi...

In this episode, Omar Khateeb sits down with Kyle Dempsey, Partner at MVM Partners , to unpack what makes a medtech company investable. Kyle shares how MVM evaluates opportunities, why commercial traction matters, and what separates strong companies from those that get overlooked. They also explore how strategics think about acquisitions, why differentiation and market size matter, and how investo...

In this episode, Omar Khateeb, Founder of Marketcraft, unpacks the real reason most MedTech startups fail to gain traction. This is not a product problem. It is a market problem. He explains how market engineering helps founders define categories, create demand, and move from early innovation to scalable growth. The conversation covers the traction gap, why product market fit is incomplete, and ho...